Eosinophilic enteropathy: Clinical Trials

2 trials for Eosinophilic enteropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow Eosinophilic enteropathy: new trials by email Literature Review of Eosinophilic enteropathy trials Research Report on Eosinophilic enteropathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
sirolimus - Eosinophilic Gastroenteritis, Eosinophilic Esophagitis
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)42013-03-072018-07-05
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
Mepolizumab - Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati242001-12-012020-07-29

Narrower conditions

Eosinophilic Esophagitis (2)  ·  Churg-Strauss Syndrome (1)  ·  Food Hypersensitivity (1)  ·  Hypereosinophilic Syndrome (1)

Broader conditions

Digestive System Diseases (2)  ·  Eosinophilia (2)  ·  Esophageal Diseases (2)  ·  Esophagitis (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Leukocyte Disorders (2)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)

Interventions

Sirolimus (1)  ·  mepolizumab (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (2)

Top investigators

Calman P Prussin, M.D. (1)  ·  Marc E. Rothenberg, MD (1)